This is a Validated Antibody Database (VAD) review about rat Gzmb, based on 60 published articles (read how Labome selects the articles), using Gzmb antibody in all methods. It is aimed to help Labome visitors find the most suited Gzmb antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Gzmb synonym: RNKP-1

BioLegend
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 6d, s4a
BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on mouse samples (fig 6d, s4a). Front Cell Infect Microbiol (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 3f
BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on mouse samples (fig 3f). Theranostics (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s1a, s4f
BioLegend Gzmb antibody (BioLegend, 515408) was used in flow cytometry on mouse samples (fig s1a, s4f). Sci Adv (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on mouse samples (fig 3f). Oncoimmunology (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2m
BioLegend Gzmb antibody (Biolegend, 515403) was used in flow cytometry on mouse samples (fig 2m). J Immunother Cancer (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:50; fig 4c
BioLegend Gzmb antibody (BioLegend, 515403) was used in flow cytometry on mouse samples at 1:50 (fig 4c). J Biol Chem (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig s10
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig s10). Oncoimmunology (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; fig 3f, 3g, s7c
BioLegend Gzmb antibody (Biolegend, 515408) was used in flow cytometry on mouse samples at 1:100 (fig 3f, 3g, s7c). Nat Nanotechnol (2022) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 5b). Commun Biol (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s4c
BioLegend Gzmb antibody (Biolegend, 515408) was used in flow cytometry on mouse samples (fig s4c). J Immunother Cancer (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; loading ...; fig s4b
BioLegend Gzmb antibody (BioLegend, 515405) was used in flow cytometry on mouse samples at 1:100 (fig s4b). iScience (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:200; loading ...; fig 3d
BioLegend Gzmb antibody (BioLegend, 515405) was used in flow cytometry on mouse samples at 1:200 (fig 3d). Proc Natl Acad Sci U S A (2021) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3e
BioLegend Gzmb antibody (Biolegend, 515406) was used in flow cytometry on human samples (fig 3e). Cell (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; loading ...; fig ev2c
BioLegend Gzmb antibody (BioLegend, 515408) was used in flow cytometry on mouse samples at 1:100 (fig ev2c). EMBO Mol Med (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 5f, 5g
BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on mouse samples (fig 5f, 5g). Science (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; loading ...; fig 8d
BioLegend Gzmb antibody (BioLegend, 515406) was used in flow cytometry on mouse samples at 1:100 (fig 8d). Nat Commun (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 2d, 2l
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 2d, 2l). Science (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s5a
BioLegend Gzmb antibody (Biolegend, 515407) was used in flow cytometry on mouse samples (fig s5a). Cell (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 10b
BioLegend Gzmb antibody (Biolegend, 515403) was used in flow cytometry on human samples (fig 10b). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:50; fig 4c, 6j
BioLegend Gzmb antibody (Biolegend, 515403) was used in flow cytometry on mouse samples at 1:50 (fig 4c, 6j). Nat Commun (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3a
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 3a). J Immunol (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 2a
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 2a). J Immunol (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:100; loading ...; fig s2b
BioLegend Gzmb antibody (Biolegend, 515403) was used in flow cytometry on mouse samples at 1:100 (fig s2b). Nat Commun (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; 1:100; loading ...; fig 3h
BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on human samples at 1:100 (fig 3h). elife (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s1d
BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig s1d). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend Gzmb antibody (Biolegend, 515403) was used in flow cytometry on mouse samples (fig 3f). Cell Rep (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s6a
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig s6a). Sci Immunol (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig s2b
BioLegend Gzmb antibody (BioLegend, 515408) was used in flow cytometry on mouse samples (fig s2b). Cell (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig s10g
BioLegend Gzmb antibody (BioLegend, 515403) was used in flow cytometry on mouse samples (fig s10g). Nature (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:200; loading ...; fig 8b
BioLegend Gzmb antibody (Biolegend, 515403) was used in flow cytometry on mouse samples at 1:200 (fig 8b). Nat Cell Biol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...
In order to evaluate mouse models of hepacivirus infection, BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on mouse samples . Science (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 4c
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 4c). Oncotarget (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 6a
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 6a). J Exp Med (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s6d
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig s6d). Cell Rep (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 4a
In order to functionally characterize herpes simplex virus-specific CD8 positive T cells, BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 4a). J Virol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 1e
In order to investigate the role of Eomes in the retention of liver natural killer cells, BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:400; loading ...; fig 3a
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on mouse samples at 1:400 (fig 3a). J Clin Invest (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 3b
In order to study T cell migration in inflammatory demyelinating lesions confined to optic nerves and spinal cord, BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 3b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 5
BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:200; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on mouse samples at 1:200 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 1
BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig 1). J Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig s1
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend Gzmb antibody (biolegend, GB11) was used in flow cytometry on human samples (fig s1). J Immunol (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (GB11)
  • immunocytochemistry; human; fig 2
In order to investigate the role of VAMP8 in exocytosis, BioLegend Gzmb antibody (BioLegend, GB11) was used in immunocytochemistry on human samples (fig 2). J Cell Biol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 1
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 4
  • flow cytometry; mouse; fig 7
BioLegend Gzmb antibody (Biolegend, GB11) was used in flow cytometry on human samples (fig 4) and in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 4
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples (fig 4). J Virol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; 5,000 ug/ml; fig 3
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on human samples at 5,000 ug/ml (fig 3). J Surg Res (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 6
BioLegend Gzmb antibody (BioLegend, GB11) was used in flow cytometry on mouse samples (fig 6). Am J Pathol (2014) ncbi
mouse monoclonal (GB11)
BioLegend Gzmb antibody (BioLegend, 515403) was used . Cancer Res (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (2C5)
  • western blot; mouse; 1:1000; loading ...; fig 8g
Santa Cruz Biotechnology Gzmb antibody (Santa Cruz Biotechnology, sc-8022) was used in western blot on mouse samples at 1:1000 (fig 8g). Nat Commun (2022) ncbi
mouse monoclonal (2C5)
  • immunohistochemistry - frozen section; human; 1:50; fig 2
In order to learn the possible role of incipient renal fibrosis by variable expression of neural cell adhesion molecule isoforms in renal tissue, Santa Cruz Biotechnology Gzmb antibody (Santa Cruz Biotechnology, sc-8022) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 2). PLoS ONE (2015) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • flow cytometry; mouse
Cell Signaling Technology Gzmb antibody (Cell Signaling Technology, 4275) was used in flow cytometry on mouse samples . EMBO Mol Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig 3d
Cell Signaling Technology Gzmb antibody (Cell Signaling Technology, 4275) was used in western blot on mouse samples at 1:2000 (fig 3d). Nat Commun (2019) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology Gzmb antibody (Cell Signaling, 4275) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s11a
In order to quantify changes in cytoplasmic and mitochondrial interactomes in response to apoptosis initiation as a function of caspase activity, Cell Signaling Technology Gzmb antibody (Cell Signaling, 4275) was used in western blot on human samples (fig s11a). Mol Syst Biol (2017) ncbi
BD Biosciences
mouse monoclonal (2C5/F5)
  • flow cytometry; mouse; loading ...; fig 4c
In order to investigate the role of TIGIT in the immune response, BD Biosciences Gzmb antibody (BD Pharmingen, 2C5/F5) was used in flow cytometry on mouse samples (fig 4c). J Clin Invest (2015) ncbi
mouse monoclonal (2C5/F5)
  • western blot; human
BD Biosciences Gzmb antibody (BD Biosciences, 2C5/F5) was used in western blot on human samples . Mol Immunol (2015) ncbi
Articles Reviewed
  1. Hou X, Shi Y, Kang X, Rousu Z, Li D, Wang M, et al. Echinococcus granulosus: The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model. Front Cell Infect Microbiol. 2022;12:983119 pubmed publisher
  2. Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. 2022;13:4461 pubmed publisher
  3. Wu B, Song M, Dong Q, Xiang G, Li J, Ma X, et al. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced PDL1 transcription in triple negative breast cancer. Theranostics. 2022;12:5086-5102 pubmed publisher
  4. Garnier L, Pick R, Montorfani J, Sun M, Brighouse D, Liaudet N, et al. IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis. Sci Adv. 2022;8:eabl5162 pubmed publisher
  5. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  6. van Vloten J, Matuszewska K, Minow M, Minott J, Santry L, Pereira M, et al. Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer. J Immunother Cancer. 2022;10: pubmed publisher
  7. Cha J, Chan L, Wang Y, Chu Y, Wang C, Lee H, et al. Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer. J Biol Chem. 2022;298:101817 pubmed publisher
  8. Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, et al. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. Oncoimmunology. 2022;11:2021619 pubmed publisher
  9. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  10. Susukida T, Kuwahara S, Song B, Kazaoka A, Aoki S, Ito K. Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity. Commun Biol. 2021;4:1137 pubmed publisher
  11. Lu C, Liu Z, Klement J, Yang D, Merting A, Poschel D, et al. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape. J Immunother Cancer. 2021;9: pubmed publisher
  12. Souza C, Ketelut Carneiro N, Milanezi C, Faccioli L, Gardinassi L, Silva J. NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8+ T cell responses. iScience. 2021;24:102548 pubmed publisher
  13. Lu M, Dravid P, Zhang Y, Trivedi S, Li A, Harder O, et al. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  14. Mondal T, Shivange G, Tihagam R, Lyerly E, Battista M, Talwar D, et al. Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies. EMBO Mol Med. 2021;13:e12716 pubmed publisher
  15. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  16. Fan Z, Tian Y, Chen Z, Liu L, Zhou Q, He J, et al. Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. EMBO Mol Med. 2020;12:e11571 pubmed publisher
  17. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  18. Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11:609 pubmed publisher
  19. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  20. Wolf Y, Bartok O, Patkar S, Eli G, Cohen S, Litchfield K, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. 2019;179:219-235.e21 pubmed publisher
  21. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  22. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  23. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  24. Kim A, Han C, Driver I, Olow A, Sewell A, Zhang Z, et al. LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8+ T Cells. J Immunol. 2019;203:1076-1087 pubmed publisher
  25. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  26. Spolski R, West E, Li P, Veenbergen S, Yung S, Kazemian M, et al. IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus. elife. 2019;8: pubmed publisher
  27. Cao Y, Trillo Tinoco J, Sierra R, Anadon C, Dai W, Mohamed E, et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019;10:1280 pubmed publisher
  28. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  29. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  30. Geary C, Krishna C, Lau C, Adams N, Gearty S, Pritykin Y, et al. Non-redundant ISGF3 Components Promote NK Cell Survival in an Auto-regulatory Manner during Viral Infection. Cell Rep. 2018;24:1949-1957.e6 pubmed publisher
  31. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed publisher
  32. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  33. Böttcher J, Bonavita E, Chakravarty P, Blees H, Cabeza Cabrerizo M, Sammicheli S, et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell. 2018;172:1022-1037.e14 pubmed publisher
  34. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed publisher
  35. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  36. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  37. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  38. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed publisher
  39. Scott N, Rogers L, Prudova A, Brown N, Fortelny N, Overall C, et al. Interactome disassembly during apoptosis occurs independent of caspase cleavage. Mol Syst Biol. 2017;13:906 pubmed publisher
  40. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed publisher
  41. Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H, et al. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocula. J Virol. 2017;91: pubmed publisher
  42. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  43. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  44. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  45. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  46. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  47. Lee Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, et al. Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol. 2016;196:3385-97 pubmed publisher
  48. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  49. Kurtulus S, Sakuishi K, Ngiow S, Joller N, Tan D, Teng M, et al. TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Invest. 2015;125:4053-62 pubmed publisher
  50. Marković Lipkovski J, Životić M, Müller C, Tampe B, Ćirović S, Vještica J, et al. Variable Expression of Neural Cell Adhesion Molecule Isoforms in Renal Tissue: Possible Role in Incipient Renal Fibrosis. PLoS ONE. 2015;10:e0137028 pubmed publisher
  51. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  52. Marshall M, Pattu V, Halimani M, Maier Peuschel M, Müller M, Becherer U, et al. VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity. J Cell Biol. 2015;210:135-51 pubmed publisher
  53. Sharma S, Chintala N, Vadrevu S, Patel J, Karbowniczek M, Markiewski M. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529-38 pubmed publisher
  54. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  55. Ebsen H, Lettau M, Kabelitz D, Janssen O. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes. Mol Immunol. 2015;65:416-28 pubmed publisher
  56. Srivastava R, Khan A, Spencer D, Vahed H, Lopes P, Thai N, et al. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic. J Immunol. 2015;194:2232-48 pubmed publisher
  57. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed publisher
  58. Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, et al. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res. 2015;194:107-13 pubmed publisher
  59. Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K, Matsushita T. B cells promote tumor immunity against B16F10 melanoma. Am J Pathol. 2014;184:3120-9 pubmed publisher
  60. Baker G, Chockley P, Yadav V, Doherty R, Ritt M, Sivaramakrishnan S, et al. Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity. Cancer Res. 2014;74:5079-90 pubmed publisher